Artelo Biosciences (ARTL) EPS (Basic) (2014 - 2025)
Artelo Biosciences (ARTL) posted quarterly EPS (Basic) of -$5.09 for Q4 2025, up 97.28% year-over-year from -$2.58 in Q4 2024, and up 48.28% quarter-over-quarter from -$9.84 in Q3 2025.
Artelo Biosciences (ARTL) EPS (Basic) (2014 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported EPS (Basic) for 12 consecutive years, with -$5.09 the latest figure, recorded in Q4 2025.
- In Q4 2025, EPS (Basic) rose 97.28% year-over-year to -$5.09; the TTM figure through Dec 2025 stood at -$22.15 (up 92.9% YoY), while the FY2025 annual figure was -$35.45, up 88.6% from the prior year.
- EPS (Basic) rose to -$5.09 in Q4 2025 per ARTL's latest filing, from -$9.84 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.02 in Q4 2021 and bottomed at -$186.99 in Q4 2024.
- Historically, EPS (Basic) has averaged -$24.94 across 5 years, with a median of -$14.91 in 2022.
- Annual changes were most pronounced in 2021 — EPS (Basic) surged 99.94% — and 2024, when it plunged 849.09%.
- Artelo Biosciences' EPS (Basic) stood at -$0.02 in 2021, then tumbled by 97372.54% to -$22.05 in 2022, then advanced by 10.66% to -$19.7 in 2023, then slumped by 849.09% to -$186.99 in 2024, then surged by 97.28% to -$5.09 in 2025.
- Business Quant data shows ARTL's EPS (Basic) at -$5.09 in Q4 2025, -$9.84 in Q3 2025, and -$10.72 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | -17.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.09 |
| Sep 30, 2025 | -9.84 |
| Jun 30, 2025 | -10.72 |
| Mar 31, 2025 | -46.92 |
| Dec 31, 2024 | -186.99 |
| Sep 30, 2024 | -23.98 |
| Jun 30, 2024 | -14.12 |
| Mar 31, 2024 | -14.67 |
| Dec 31, 2023 | -19.70 |
| Sep 30, 2023 | -16.15 |
| Jun 30, 2023 | -11.39 |
| Mar 31, 2023 | -14.51 |
| Dec 31, 2022 | -22.05 |
| Sep 30, 2022 | -15.16 |
| Jun 30, 2022 | -15.85 |
| Mar 31, 2022 | -12.27 |
| Nov 30, 2021 | -0.02 |
| Aug 31, 2021 | -0.05 |
| May 31, 2021 | -27.19 |
| Feb 28, 2021 | -32.04 |